Wenlong Zhong

South China University of Technology — China

Medicine · Health Sciences

14h-index675citations107works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(53), Bladder and Urothelial Cancer Treatments(37), Immune Response and Inflammation(30), Immune cells in cancer(25), Immunotherapy and Immune Responses(11)

Publications107 total

Spatial-Aware Adaptive Fusion for Robust Object Detection in Adverse Environments
Pattern Recognition Letters·2026
B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity
Cancer Cell·2026· 1 citedOpen Access
Nucleophosmin 1 lactylation in graft kidney induces ferroptotic trigger waves that exacerbate delayed graft function
Nature Communications·2025Open Access
Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair
Signal Transduction and Targeted Therapy·2025· 14 citedOpen Access
Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer
Cancer Immunology Immunotherapy·2025Open Access
Evaluating the efficacy and safety of bladder-sparing regimen with Disitamab Vedotin combined with Toripalimab and pelvic lymph node dissection in muscle-invasive bladder cancer patients: study protocol of a multicenter single-arm phase II trial
BMC Cancer·2025· 1 citedOpen Access
Identification of Multi‐Landscape and Cell Interactions in the Tumor Microenvironment Through High‐Coverage Single‐Cell Sequencing
Small Methods·2025· 1 cited
Modifiable factors affects cancer-specific survival: findings from a large population-based prospective cohort study
Journal of Translational Medicine·2025· 2 citedOpen Access
From pixels to prognosis: radiomics and AI in Alzheimer’s disease management
Frontiers in Neurology·2025· 6 citedOpen Access
Environment-Independent Fusion for Robust Object Detection in Adverse Environments
Lecture notes in computer science·2024
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
Nature Cancer·2024· 16 cited
Correlation of noninvasive imaging of tumour-infiltrating lymphocytes with survival and BCG immunotherapy response in patients with bladder cancer: a multicentre cohort study
International Journal of Surgery·2024· 2 citedOpen Access
Fine-Grained Few-Shot Image Classification Based on Feature Dual Reconstruction
Electronics·2024· 2 citedOpen Access
Identification of Multi-landscape and Cell Interactions in the Tumor Microenvironment through High-Coverage Single-Cell Sequencing
2024Open Access
Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer
EBioMedicine·2024· 25 citedOpen Access
Hematoxylin-eosin staining based immune microenvironment subtypes to guide prognostic stratification for locally progressive upper tract urothelial carcinoma
European Urology·2024
PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay
Cancer Cell·2024· 106 citedOpen Access
Tumor-associated neutrophils suppress CD8+ T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis
British Journal of Cancer·2024· 31 citedOpen Access
Supplementary Materials and Methods from <i>FGFR3</i> Alterations in Bladder Cancer Stimulate Serine Synthesis to Induce Immune-Inert Macrophages That Suppress T-cell Recruitment and Activation
2023Open Access
Supplementary Figures 1-6 from <i>FGFR3</i> Alterations in Bladder Cancer Stimulate Serine Synthesis to Induce Immune-Inert Macrophages That Suppress T-cell Recruitment and Activation
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Tianxin Lin(34), Bo Wang(20), Jian Huang(18), Ziwei Ou(16), Junyu Chen(15), Xiaodong Huang(14), Ke Chen(13), Tenghao Yang(13), Xuesong Li(12), Liqun Zhou(12), Lin Huang(12), Wenjian Liao(12), Yiyu Sheng(12), Zhixing Guo(12), Wenjuan Yang(12), Jian Huang(9), Junyu Chen(8), Kun Xia(7), Longhao Xu(6), Daqin Wu(6)